AIDS Funding Outlook Hazy

WASHINGTON-The drive to quadruple federal funding for AIDS research to $1 billion annually faces an uncertain future within the Reagan administration and in Congress. A star-studded joint committee of the National Academy of Sciences and the Institute of Medicine has urged the massive increase after an intensive six-month study. Its report, issued late last month, also chides the National Institutes of Health for not enlisting enough university researchers in its effort to better understand the

Written byAmy Mcdonald
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

WASHINGTON-The drive to quadruple federal funding for AIDS research to $1 billion annually faces an uncertain future within the Reagan administration and in Congress.

A star-studded joint committee of the National Academy of Sciences and the Institute of Medicine has urged the massive increase after an intensive six-month study. Its report, issued late last month, also chides the National Institutes of Health for not enlisting enough university researchers in its effort to better understand the basic nature of the deadly virus.

"If the senator has his way, funding will be increased," said a spokesman for Sen. Lowell Weicker (R-Conn.), outgoing chairman of the Senate appropriations sub-committee that handles the majority of AIDS funding. "But it's hard to say now what lies ahead, and whether a $1 billion budget is realistic for 1990."

The White House Office of Science and Technology Policy is "looking at the possibility of developing a budget ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies